Novogene Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,257	2,202	2,104	1,998	1,925	1,864
Other Revenue	7.23	7.23	7.11	4.61	0.86	2.73
Revenue	2,264	2,210	2,111	2,002	1,926	1,866
Revenue Growth (YoY)	5.56%	4.66%	5.46%	3.97%	3.17%	25.26%
Cost of Revenue	1,292	1,272	1,194	1,150	1,077	1,072
Gross Profit	972.5	937.85	917.55	852.43	849.07	793.9
Selling, General & Admin	606.74	588.85	564.3	556.7	503.88	423.81
Research & Development	166.48	159.93	131.45	124.18	125.57	145.29
Other Operating Expenses	4.13	3.66	3.69	-21.05	-8.7	-25.3
Operating Expenses	818.06	798.84	721.99	675.46	648.03	563.57
Operating Income	154.45	139.01	195.57	176.97	201.04	230.33
Interest Expense	-2.02	-1.84	-1.3	-2.13	-2.15	-2.92
Interest & Investment Income	25.2	27.92	31.41	27.47	11.89	8.27
Currency Exchange Gain (Loss)	10.33	10.33	2.61	13.21	11.78	-6.47
Other Non Operating Income (Expenses)	-11.44	-2.19	-0.94	-2.31	-4.36	-2.72
EBT Excluding Unusual Items	176.51	173.23	227.35	213.22	218.21	226.49
Gain (Loss) on Sale of Investments	11.75	15.56	14.46	-2.25	-6.39	23.33
Gain (Loss) on Sale of Assets	0.16	0.14	-2.08	-2.31	-5.3	-3.58
Asset Writedown	0	-	-9.15	-	-8.46	0.03
Other Unusual Items	3.91	3.98	-5.86	3.98	10.51	0.18
Pretax Income	192.33	192.91	224.73	212.63	208.56	246.46
Income Tax Expense	24.87	21.43	20.89	29.41	27.02	17.58
Earnings From Continuing Operations	167.46	171.48	203.84	183.22	181.53	228.89
Minority Interest in Earnings	-4.94	-4.54	-7.05	-5.17	-4.3	-3.69
Net Income	162.52	166.95	196.79	178.06	177.23	225.2
Net Income to Common	162.52	166.95	196.79	178.06	177.23	225.2
Net Income Growth	-20.08%	-15.16%	10.52%	0.47%	-21.30%	516.32%
Shares Outstanding (Basic)	407	407	410	405	403	387
Shares Outstanding (Diluted)	407	407	410	405	403	387
Shares Change (YoY)	-2.81%	-0.68%	1.31%	0.47%	4.14%	5.86%
EPS (Basic)	0.40	0.41	0.48	0.44	0.44	0.58
EPS (Diluted)	0.40	0.41	0.48	0.44	0.44	0.58
EPS Growth	-17.76%	-14.58%	9.09%	-	-24.14%	480.00%
Free Cash Flow	131.96	112.72	202.97	217.5	86.73	181.47
Free Cash Flow Per Share	0.33	0.28	0.49	0.54	0.21	0.47
Dividend Per Share	0.045	0.045	0.050	0.048	0.047	0.060
Dividend Growth	-10.00%	-10.00%	5.26%	1.06%	-21.67%	-
Gross Margin	42.95%	42.44%	43.46%	42.58%	44.09%	42.54%
Operating Margin	6.82%	6.29%	9.26%	8.84%	10.44%	12.34%
Profit Margin	7.18%	7.56%	9.32%	8.89%	9.20%	12.07%
Free Cash Flow Margin	5.83%	5.10%	9.61%	10.86%	4.50%	9.72%
EBITDA	272.97	261.57	334.26	304.4	313.1	347.24
EBITDA Margin	12.06%	11.84%	15.83%	15.20%	16.26%	18.61%
D&A For EBITDA	118.52	122.56	138.7	127.43	112.05	116.91
EBIT	154.45	139.01	195.57	176.97	201.04	230.33
EBIT Margin	6.82%	6.29%	9.26%	8.84%	10.44%	12.34%
Effective Tax Rate	12.93%	11.11%	9.30%	13.83%	12.96%	7.13%
Revenue as Reported	2,264	2,210	2,111	2,002	1,926	1,866
Advertising Expenses	-	88.97	68.06	59.97	28.59	20.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.